HCG Cancer Centre's World Cancer Day 2024 Awareness Center in Bengaluru

HCG Cancer Center, Bangalore has launched several initiatives through the 'Power of Good Wishes' campaign, inspired by the heart-warming faith 'Jo dawa nahi kar paati, wo dua kar paati hai' (What can't medicine do) on Cancer Day.

ACS and Pfizer's $15M Cancer Care Disparity Initiative

The American Cancer Society (ACS) and Pfizer Inc. announced the launch of "Changing the Odds: A Partnership to Improve Cancer Outcomes," a three-year plan to address gaps in cancer care.

JB Pharma Q3 FY24 Net Profit Soars 26% to Rs. 134 Crore

JB Chemicals and Pharmaceuticals Ltd (JB Pharma), one of India's fastest-growing pharmaceutical companies, announced its financial results for the quarter that ended December 31, 2023.

Molbio Diagnostics Launches 'EDGE' Healthcare Innovation Program

Molvio Diagnostics, a leader in in-house diagnostic diagnostics, has launched 'EDGE,' a state-of-the-art collaborative program dedicated to accelerating gaming therapy technologies

Lupin Secures Nod From US FDA for Bromfenac Ophthalmic Solution

Lupine Limited (hereafter Lupin), an international pharmaceutical company, has received approval from the US Food and Drug Administration (FDA) to submit a New Drug Application for Bromfenac 0.075% Ophthalmic Solution to be marketed as a vaccine

Metropolis Enhances Diagnostic Center in Ratlam, MP

Metropolis Healthcare, India's leading provider of diagnostic services has opened a state-of-the-art diagnostic center in Ratlam, Madhya Pradesh.

Agilis Robotics Introduces Significant Advancements in Endoluminal Surgery

Agilis Mechanical technology, a main pioneer in careful mechanical technology, is leading a change in perspective in the field of "incisionless" endoluminal medical procedure. The company has made significant technological advancements by...

Pharma Giant Novartis To Acquire MorphoSys For USD 2.9 Billion

Drugmaker Novartis AG said it will procure MorphoSys AG, an engineer of malignant growth therapies, for 2.7 billion euros ($2.9 billion), adding a promising interesting bone-marrow disease treatment possibility to its portfolio. Novartis will...

MedGenome Study: Uncovering Parkinson's Genes in Young Indians

MedGenome, a leading global technology company in South Asia, and the Parkinson's Research Alliance of India (PRAI) conducted a study that identified rare and common variants based on the Polygenic Risk Score (PRS) in Young Onset.

FDA Clears Acepodia's ACE2016 IND Application

Acepodia's, a clinical biotechnology company, is developing best-in-class therapeutics with its unique antibody-cell conjugate (ACC) and allergenic gamma delta 2(d2) T cells to address cancer treatment areas, one of the US. The food.

on the deck


Most Viewed

Editor's Guest


© 2025 India Pharma Outlook. All Rights Reserved.